Skip to main content


Guideline Updates

Guideline Updates
March 03, 2021
The NCCN released an update to include cemiplimab-rwlc as a preferred, category 1, treatment option for PD-L1 expression-positive NSCLC ≥50%.
Guideline Updates
March 03, 2021
The NCCN released an update to include cemiplimab-rwlc as a preferred, category 1, treatment option for PD-L1…
Guideline Updates
December 14, 2020
The NCCN recently released an updated version of its clinical practice guidelines for CLL/SLL.
Guideline Updates
November 18, 2020
ASCO published a guideline update about the selection of optimal adjuvant chemotherapy regimens and targeted therapy…
Guideline Updates
JCP Editors, August 07, 2020
ASH has published evidence-based guidelines to help older adults with newly diagnosed AML and their health care…
Guideline Updates
JCP Editors, July 13, 2020
The guideline update includes updates in second-line and subsequent therapy for follicular lymphoma as well as third-…
Guideline Updates
JCP Editors, June 30, 2020
The new clinical guideline features 38 recommendations pertaining to early evaluation and counseling, metastatic…
Guideline Updates
JCP Editors, June 29, 2020
The American Gastroenterological Association Institute Clinical Practice Update provides new recommendations for…
Guideline Updates
JCP Editors, June 22, 2020
The updated guideline features changes to the sections for papillary, follicular, medullary, and anaplastic carcinomas.
Guideline Updates
JCP Editors, June 17, 2020
The new clinical guideline from ASTRO outlines indications and best practices for external beam radiation therapy and…
Guideline Updates
JCP Editors, June 15, 2020
A multidisciplinary, consensus-driven, genetic testing implementation framework for prostate cancer offers novel…
Back to Top